Index

Show indicators by:

  • Cancer Control Domain
  • Disease Site
  • Dashboard
  • Disease Site
    • Breast
      • Breast cancer screening
      • Screening in underserved populations
      • Breast cancer diagnosis wait time
      • Capture of stage
      • Stage distribution
      • Surgery
        • Breast cancer resections that are mastectomies
        • The use of breast-conserving surgery versus mastectomies for breast cancer resections
      • Radiation therapy
        • Post-operative radiation therapy for stage I or II breast cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Breast cancer screening outside recommended guidelines
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Colorectal
      • Colorectal cancer screening
      • Geographic variation in colorectal cancer risk
      • Screening in underserved populations
      • Colorectal cancer diagnosis wait time
      • Capture of stage
      • Stage distribution
      • Surgery
        • Removal and examination of 12 or more lymph nodes in colon resections
        • Resection rates for stage II or III rectal cancer, stage III colon cancer and stage II or IIIA non-small cell lung cancer patients
      • Radiation therapy
        • Pre-operative radiation therapy for patients with stage II or III rectal cancer
      • Post-operative chemotherapy for stage III colon cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Lung
      • Capture of stage
      • Stage distribution
      • Geographic variation in lung cancer risk
      • Resection rates for stage II or IIIA Non-snmall cell lung cancer patients
      • Post-operative chemotherapy for stage II or IIIA non-small cell lung cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Prostate
      • PSA testing
      • Prostate risk profile
      • Capture of stage
      • Stage distribution
      • Prostate wait times for surgery
      • Prostate wait times for radiation therapy
      • Radical prostatectomy: open versus laparoscopic surgery
      • Prostate patterns of care: radiation and surgical treatment
      • Prostate access to palliative radiation
      • Prostate clinical trials participation
      • Adult clinical trial participation
      • Prostate cancer research investment
      • Cancer research investment
      • Incidence & Mortality Rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Cervical
      • Human papillomavirus (HPV) vaccination
      • Cervical cancer screening
      • Screening in underserved populations
    • Pancreas
      • Incidence and mortality rates
    • Stage Distribution
  • Province & Territory
  • 1. Prevention
  • 2. Screening
  • 3. Diagnosis
  • 4. Treatment
  • 5. Person-Centred Perspective
  • 6. Research
  • 7. Appropriateness
  • 8. Long-term outcomes
  • Smoking prevalence
  • Smoking behaviours in current cancer patients
  • Smoking cessation
  • Second-hand smoke exposure
  • Geographic variation in lung cancer risk
  • Alcohol consumption
  • Adult overweight and obesity
  • Active transportation
  • Physical inactivity
  • Human papillomavirus (HPV) vaccination
  • Fruit and vegetable consumption
  • Geographic variation in colorectal cancer risk
  • Cervical cancer screening
  • Breast cancer screening
  • Colorectal cancer screening
  • PSA testing
  • Screening in underserved populations
  • Breast cancer diagnosis wait times
  • Colorectal cancer diagnosis wait times
  • Capture of stage
  • Stage distribution
  • Prostate risk profile
  • Surgery
  • Radiation therapy
  • Systemic therapy
  • Removal and examination of 12 or more lymph nodes in colon resections
  • Resection rates for stage II or III rectal cancer, stage III colon cancer and stage II or IIIA non-small cell lung cancer patients
  • The use of breast-conserving surgery versus mastectomies for breast cancer resections
  • Breast cancer resections that are mastectomies
  • High-risk, resource-intensive surgeries for esophageal, pancreatic, liver, lung and ovarian cancers in Canada
  • Prostate wait times for surgery
  • Radical prostatectomy: open versus laparoscopic surgery
  • Radiation therapy wait times
  • Radiation therapy utilization and capacity
  • Pre-operative radiation therapy for patients with stage II or III rectal cancer
  • Post-operative radiation therapy for patients with stage I or II breast cancer
  • Prostate wait times for radiation therapy
  • Prostate patterns of care: radiation and surgical treatment
  • Post-operative chemotherapy for stage III colon cancer patients
  • Post-operative chemotherapy for patients with stage II or IIIA non-small cell lung cancer
  • Screening for distress
  • Patient satisfaction
  • Place of death
  • Prostate access to palliative radiation
  • Adult clinical trial participation
  • Prostate clinical trials participation
  • Pediatric clinical trial participation
  • Cancer research investment
  • Prostate cancer research investment
  • Breast cancer screening outside of guidelines
  • Breast cancer mastectomies done as day surgery
  • Intensive care use in the last two weeks of life
  • Breast cancer
  • Lung cancer
  • Colorectal cancer
  • Prostate cancer
  • Pancreatic cancer
  • Five-year net survival by income quintile for several cancers in Canada
System Performance Logo
System Performance
  • About
  • Reports
  • Français
  • Home
  • Cancer control domain
  • 8. Long-term outcomes
  • Prostate cancer

Prostate cancer

  • Charts and Tables

    Charts and Tables

    Figure 8.13

    Incidence and mortality rates† for prostate cancer, Canada — from 1992 to 2014

    • Download & Export

      Figure

      •  

      Data Table

      • CSV
      • Excel
      • Json
      • XML

    † Age-standardized to 2011 Canadian population.

    QC: Cancer incidence data not available for 2011, 2012 and 2013 diagnosis years. The 2010 Quebec data have been copied forward into 2011, 2012 and 2013.

    Data source: Statistics Canada, Canadian Cancer Registry (CANSIM).

    Data Table

    YearMeasureAge-standardized incidence rate (per 100,000 population)Lower bound of 95% confidence intervalUpper bound of 95% confidence interval
    1992Incidence167.3164.5170.0
    1993Incidence186.3183.4189.1
    1994Incidence171.7169.0174.4
    1995Incidence149.4146.9151.9
    1996Incidence146.7144.3149.1
    1997Incidence154.1151.6156.5
    1998Incidence153.9151.4156.3
    1999Incidence159.7157.3162.2
    2000Incidence166.5164.0168.9
    2001Incidence177.5175.0180.0
    2002Incidence165.4163.0167.8
    2003Incidence161.2158.9163.5
    2004Incidence164.2161.9166.5
    2005Incidence163.7161.5165.9
    2006Incidence169.3167.1171.6
    2007Incidence168.2166.0170.3
    2008Incidence154.4152.3156.4
    2009Incidence151.0149.0153.0
    2010Incidence144.8142.9146.8
    2011Incidence147.4145.5149.3
    2012Incidence129.2127.5131.0
    2013Incidence119.1117.4120.7
    1992Mortality44.743.146.3
    1993Mortality44.743.246.3
    1994Mortality44.543.046.1
    1995Mortality44.943.446.5
    1996Mortality42.240.743.6
    1997Mortality41.540.142.9
    1998Mortality40.839.442.2
    1999Mortality39.438.140.8
    2000Mortality39.237.940.5
    2001Mortality39.237.940.5
    2002Mortality37.135.838.3
    2003Mortality35.834.637.0
    2004Mortality35.133.936.3
    2005Mortality32.931.834.0
    2006Mortality31.430.332.5
    2007Mortality31.029.932.0
    2008Mortality30.429.431.4
    2009Mortality29.628.630.6
    2010Mortality29.328.430.3
    2011Mortality27.426.628.4
    2012Mortality26.325.527.2
    2013Mortality26.725.927.6
    2014Mortality27.026.227.8

    + Expand Table

    † Age-standardized to 2011 Canadian population.

    QC: Cancer incidence data not available for 2011, 2012 and 2013 diagnosis years. The 2010 Quebec data have been copied forward into 2011, 2012 and 2013.

    Data source: Statistics Canada, Canadian Cancer Registry (CANSIM).

    Figure 8.16

    Incidence rates for prostate cancer, by stage at diagnosis and province, age-standardized to the 2011 Canadian population — 2015 diagnosis year

    • Download & Export

      Figure

      •  

      Data Table

      • CSV
      • Excel
      • Json
      • XML

    "– " Data not available.

    Data source: Provincial cancer agencies and programs.

    Data Table

    JurisdictionStage at DiagnosisAge-standardized incidence (rate per 100,000 women)
    BCStage I17.2
    BCStage II59.7
    BCStage III17
    BCStage IV19.1
    ABStage I30.2
    ABStage II83.2
    ABStage III19.3
    ABStage IV21.2
    SKStage I25.9
    SKStage II78.3
    SKStage III19.2
    SKStage IV28.3
    MBStage I16.1
    MBStage II87.9
    MBStage III14
    MBStage IV25.6
    ONStage I27.7
    ONStage II68
    ONStage III16.5
    ONStage IV17.5
    QCStage I–
    QCStage II–
    QCStage III–
    QCStage IV–
    NBStage I41
    NBStage II67
    NBStage III12
    NBStage IV16
    NSStage I26.3
    NSStage II56.3
    NSStage III15.4
    NSStage IV18.7
    PEStage I57.2
    PEStage II50.9
    PEStage III14.3
    PEStage IV14
    NLStage I38.4
    NLStage II73.2
    NLStage III28.6
    NLStage IV14.3
    YTStage I–
    YTStage II–
    YTStage III–
    YTStage IV–
    NTStage I–
    NTStage II–
    NTStage III–
    NTStage IV–
    NUStage I–
    NUStage II–
    NUStage III–
    NUStage IV–

    + Expand Table

    "– " Data not available.

    Data source: Provincial cancer agencies and programs.

  • Data specifications

    Data specifications

    Cancer deaths

    Definition: Age-standardized mortality rates per 100,000 population died from the specified cancer sites

    Rationale for measurement: Data and metrics regarding age-standardized mortality rates are needed to provide an accurate measure of the burden of disease across Canada.

    Measurement timeframe: Years 1992 to 2014

    Denominator: Canadian population estimates by year, sex and age group

    Numerator: Number of deaths in the measure timeframe from the specified cancers

    Exclusion criteria: For breast cancer, males were excluded

    Data availability: All provinces and territories

    Stratification: 

    1. By cancer site: prostate, lung, breast (female), colorectal
    2. By sex if applicable
    3. By year

    Data sources: Statistics Canada, Vital Statistics Death Database

    Data retrieval date: December 2017

    Variables details:

    1. Up to the year 1999, the cause of deaths from invasive cancer sites/types were defined in ICD-9:
      • Prostate: 185
      • Lung: 162
      • Breast (female): 174
      • Colorectal: 153-154
    2. After the year 1999, the cause of deaths from invasive cancer sites/types were defined in ICD-10:
      • Prostate: C61.9
      • Lung: C34
      • Breast: C50
      • Colorectal: C18, C19.9, C20.9, C26.0

    Notes from jurisdictions: Not applicable

    Methodology notes: 

    1. Data presented were jurisdictions combined for ages 0+.
    2. The cause of death from cancer sites/types were classified by World Health Organization, International Classification of Diseases (ICD). Up to the year 1999, the Ninth Edition (ICD-9) was used. After the year 1999, the Tenth Edition (ICD-10) was used.
    3. Mortality rates were age standardized to the Canadian 2011 population using direct method.

    Changes to definition compared to previous years: Not applicable


    Cancer incidence

    Definition: Age-standardized incidence rates per 100,000 population diagnosed for the specified cancer sites

    Rationale for measurement: Data and metrics regarding age-standardized incidence rates and trends are needed to provide an accurate measure of the burden of disease across Canada.

    Measurement timeframe: Years 1992 to 2013

    Denominator: Canadian population estimates by year, sex and age group

    Numerator: Number of new invasive cases for the specified cancers diagnosed in the measure timeframe

    Exclusion criteria: For breast cancer, males were excluded

    Data availability: Data were aggregated at national level:

    • All provinces and territories, except QC which 2010 data have been copied forward to 2011, 2012 and 2013.

    Stratification: Data were aggregated at national level:

    • By cancer site: prostate, lung, breast (female), colorectal
    • By sex if applicable
    • By year

    Data source: Statistics Canada, Canadian Cancer Registry (CANSIM table 103-0554

    Data retrieval date: October 2017

    Variables details: The cancer sites/types were defined in ICD-O3 with behavior code 3 (invasive):

    • Prostate: 9
    • Lung: C34
    • Breast: C50
    • Colorectal: C18, C19.9, C20.9, C26.0

    Cancer cases with histology types 9590-9992 (leukemia, lymphoma and multiple myeloma), 9050-9055 (mesothelioma) and 9140 (Kaposi sarcoma) are excluded.

    Notes from jurisdictions: Not applicable

    Methodology notes:

    1. Data presented were jurisdictions combined for ages 0+.
    2. The cancer incidence sites/types were classified by World Health Organization, International Classification of Diseases for Oncology, Third Edition (ICD- O-3). The International Agency for Research on Cancer (IARC) rules were used for determining multiple primaries sites.
    3. QC incidence data were not available for 2011 onward, incidence cases and population data in 2010 were copied forward to 2011, 2012 and 2013
    4. Incidence rates were age standardized to the Canadian 2011 population using direct method.

    Changes to definition compared to previous years: Not applicable

  • Related indicators

    Related Indicators

    PSA testing

    Percentage of men (aged ≥ 35) reporting at least one PSA test† in the past one year, two years or ever, by province/territory – 2010-2013 reporting years combined
    View this indicator
    Stage distribution

    Distribution of cases by stage at diagnosis for prostate cancer – 2013 diagnosis year
    View this indicator
    Prostate risk profile

    Criteria for which risk categories were assigned for non-metastatic prostate cancer cases based on the definition set out by Genitourinary Radiation Oncologists of Canada
    Table 2.1
    View this indicator
    Prostate patterns of care: radiation and surgical treatment

    Percentage of low-risk prostate cancer patients (men aged ≥ 35) receiving various types of radiation therapy ,† by province — 2010 diagnosis year
    View this indicator
    Prostate clinical trials participation

    Ratio of adult prostate cancer patients enrolled in clinical trial to number of incident cases, by province — 2013 enrolment year
    View this indicator
  • About Us
  • Careers
  • Contact
  • Media centre
  • Share your feedback
  • About our new site

  • Français Language toggle.

Other related sites:

  • Canadian Partnership for Tomorrow’s Health
  • Canadian Cancer Research Alliance
  • Canadian Cancer Trials
  • facebook
  • twitter
  • youtube
  • linkedin
    CPAC Logo

    Questions about cancer?

    For information about cancer treatment and support for patients, please contact the Canadian Cancer Society at 1-888-939-3333 or by completing this online form.

  • AODA compliance
  • Privacy policy
  • Terms of use
  • FAQ
  • Site map
  • About this site
© Canadian Partnership Against Cancer Corporation